Tissue development 'roadmap' created to guide stem cell medicine

Computer algorithm also provides 'quality assurance' for lab-created cells

2014-08-14

(Press-News.org) In a boon to stem cell research and regenerative medicine, scientists at Boston Children's Hospital, the Wyss Institute for Biologically Inspired Engineering at Harvard University and Boston University have created a computer algorithm called CellNet as a "roadmap" for cell and tissue engineering, to ensure that cells engineered in the lab have the same favorable properties as cells in our own bodies. CellNet and its application to stem cell engineering are described in two back-to-back papers in the August 14 issue of the journal Cell.

Scientists around the world are engaged in culturing pluripotent stem cells (capable of forming all the body's tissues) and transforming them into specialized cell types for use in research and regenerative medicine. Available as an Internet resource for any scientist to use, CellNet provides a much needed "quality assurance" measure for this work.

The two papers also clarify uncertainty around which methods are best for stem cell engineering, and should advance the use of cells derived from patient tissues to model disease, test potential drugs and use as treatments. For example, using CellNet, one of the studies unexpectedly found that skin cells can be converted into intestinal cells that were able to reverse colitis in a mouse model.

"To date, there has been no systematic means of assessing the fidelity of cellular engineering—to determine how closely cells made in a petri dish approximate natural tissues in the body," says George Q. Daley, MD, PhD, Director of the Stem Cell Transplantation Program at Boston Children's and senior investigator on both studies. "CellNet was developed to assess the quality of engineered cells and to identify ways to improve their performance."

Gene Signatures

CellNet applies network biology to discover the complex network of genes that are turned on or off in an engineered cell, known as the cell's Gene Regulatory Network or GRN. It then compares that network to the cell's real-life counterpart in the body, as determined from public genome databases. Through this comparison, researchers can rigorously and reliably assess:

The quality of induced pluripotent stem cells (iPS cells) made by reprogramming blood cells or skin cells The quality of specialized cells—such as liver, heart, muscle, brain or blood cells—made from either iPS cells or embryonic stem cells The quality of specialized cells made from other specialized cells (such as liver cells made directly from skin cells) What specific improvements need to be made to the engineering process

"CellNet will also be a powerful tool to advance synthetic biology—to engineer cells for specific medical applications," says James Collins, PhD, Core Faculty member at the Wyss Institute and the William F. Warren Distinguished Professor at Boston University, co-senior investigator on one of the studies.

Putting CellNet to the Test

The researchers—including co-first authors Patrick Cahan, PhD and Samantha Morris, PhD, of Boston Children's, and Hu Li, PhD, of the Mayo Clinic, first used CellNet to assess the quality of eight kinds of cells created in 56 published studies.

In a second study, they applied CellNet's teachings to a recurring question in stem cell biology: Is it feasible to directly convert one specialized cell type to another, bypassing the laborious process of first creating an iPS cell? This study looked at two kinds of directly converted cells: liver cells made from skin cells, and macrophages made from B cells.

"Most attempts to directly convert one specialized cell type to another have depended on a trial and error approach," notes Cahan, principle architect of CellNet and a post-doctoral scientist in the Daley lab. "Until now, quality control metrics for engineered cells have not gotten to the core defining features of a cell type."

In both test cases, CellNet showed that the engineered cells hadn't completely converted, retaining some characteristics of their cells of origin—but pointed to specific genetic tweaks that could be done in the lab to fix the problem.

CellNet also pointed out some useful properties that weren't apparent before. "We found that liver-like cells made from mouse skin were actually more like intestinal cells," says Morris. "In fact, the converted skin cells could engraft into mice with inflammatory bowel disease—Crohn's or ulcerative colitis. After a short time, the cells became highly similar to native colon cells and assisted healing of the damaged tissue, a finding that surprised and excited us."

Guidance for Stem Cell Engineering

Together, the two studies establish some general principles for stem cell science:

The GRN of iPS cells created by reprogramming a mature cell is nearly identical to that of stem cells made from embryos, confirming that iPS cells are a good raw material for creating specialized cells. Once engineered cells are engrafted into laboratory mice, their GRN becomes even closer to that of the true target tissue, indicating that the body's own tissues contribute signals to enhance the performance of transplanted cells. Differentiating pluripotent stem cells into specific tissues is currently more effective than attempting to convert one specialized cell directly to another, creating cells whose GRNs are much like those of cells in the body. Most specialized cells made from other specialized cells retain some "memory" of their cell of origin, making them less than ideal for certain uses but better for others. INFORMATION: Supporters of the studies include the National Institutes of Health (grant #s R24DK092760, UO1-HL100001, P50HG005550, 1K01DK096013, 2T32HL06698, 5T32HL007623 and R01DK082889), the National Institute of Diabetes and Digestive and Kidney Diseases (K01DK096013), the National Heart, Lung, and Blood Institute (T32HL066987 and T32HL007623), the Children's Hospital Stem Cell Program, the Howard Hughes Medical Institute, Alex's Lemonade Stand Foundation, the Mayo Clinic, the Ellison Medical Foundation and the Doris Duke Medical Foundation.

Boston Children's Hospital is home to the world's largest research enterprise based at a pediatric medical center, where its discoveries have benefited both children and adults since 1869. More than 1,100 scientists, including seven members of the National Academy of Sciences, 14 members of the Institute of Medicine and 14 members of the Howard Hughes Medical Institute comprise Boston Children's research community. Founded as a 20-bed hospital for children, Boston Children's today is a 395-bed comprehensive center for pediatric and adolescent health care. Boston Children's is also the primary pediatric teaching affiliate of Harvard Medical School. For more information about research and clinical innovation at Boston Children's, visit: http://vectorblog.org.

The Wyss Institute for Biologically Inspired Engineering at Harvard University uses Nature's design principles to develop bioinspired materials and devices that will transform medicine and create a more sustainable world. Working as an alliance among all of Harvard's Schools, and in partnership with Beth Israel Deaconess Medical Center, Brigham and Women's Hospital, Boston Children's Hospital, Dana Farber Cancer Institute, Massachusetts General Hospital, the University of Massachusetts Medical School, Spaulding Rehabilitation Hospital, Boston University, Tufts University, and Charité - Universitätsmedizin Berlin, and the University of Zurich, the Institute crosses disciplinary and institutional barriers to engage in high-risk research that leads to transformative technological breakthroughs. By emulating Nature's principles for self-organizing and self-regulating, Wyss researchers are developing innovative new engineering solutions for healthcare, energy, architecture, robotics, and manufacturing. These technologies are translated into commercial products and therapies through collaborations with clinical investigators, corporate alliances, and new start-ups.

The Boston University College of Engineering offers a wide range of undergraduate, graduate and professional degrees in foundational and emerging engineering disciplines. Underlying the College's educational efforts is its commitment to creating Societal Engineers who have an appreciation for how the engineer's unique skills can be used to improve our quality of life. Ranked among the nation's best engineering research institutions, the College's faculty attracts more than $50 million in external research support annually.

ELSE PRESS RELEASES FROM THIS DATE:

Antibodies, together with viral 'inducers,' found to control HIV in mice

2014-08-14

Although HIV can now be effectively suppressed using anti-retroviral drugs, it still comes surging back the moment the flow of drugs is stopped. Latent reservoirs of HIV-infected cells, invisible to the body's immune system and unreachable by pharmaceuticals, ensure that the infection will rebound after therapy is terminated. But a new strategy devised by researchers at Rockefeller University harnesses the power of broadly neutralizing antibodies against HIV, along with a combination of compounds that induce viral transcription, in order to attack these latent reservoirs ...

Researchers identify a mechanism that stops progression of abnormal cells into cancer

2014-08-14

(Boston)-- Researchers from Boston University School of Medicine (BUSM) report that a tumor suppressor pathway, called the Hippo pathway, is responsible for sensing abnormal chromosome numbers in cells and triggering cell cycle arrest, thus preventing progression into cancer. Although the link between abnormal cells and tumor suppressor pathways—like that mediated by the well known p53 gene—has been firmly established, the critical steps in between are not well understood. According to the authors, whose work appears in Cell, this work completes at least one of the ...

Researchers develop strategy to combat genetic ALS, FTD

2014-08-14

JACKSONVILLE, Fla. — A team of researchers at Mayo Clinic and The Scripps Research Institute in Florida have developed a new therapeutic strategy to combat the most common genetic risk factor for the neurodegenerative disorders amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease) and frontotemporal dementia (FTD). In the Aug. 14 issue of Neuron, they also report discovery of a potential biomarker to track disease progression and the efficacy of therapies. The scientists developed a small-molecule drug compound to prevent abnormal cellular processes caused by a ...

Inside the cell, an ocean of buffeting waves

2014-08-14

Cambridge, Mass. – August 14, 2014 – Conventional wisdom holds that the cytoplasm of mammalian cells is a viscous fluid, with organelles and proteins suspended within it, jiggling against one another and drifting at random. However, a new biophysical study led by researchers at Harvard University challenges this model and reveals that those drifting objects are subject to a very different type of environment. The cytoplasm is actually an elastic gel, it turns out, so it puts up some resistance to simple diffusion. But energetic processes elsewhere in the cell—in the cytoskeleton, ...

Forcing chromosomes into loops may switch off sickle cell disease

2014-08-14

Scientists have altered key biological events in red blood cells, causing the cells to produce a form of hemoglobin normally absent after the newborn period. Because this hemoglobin is not affected by the inherited gene mutation that causes sickle cell disease, the cell culture findings may give rise to a new therapy for the debilitating blood disorder. The novel approach uses protein-engineering techniques to force chromatin fiber, the substance of chromosomes, into looped structures that contact DNA at specific sites to preferentially activate genes that regulate hemoglobin. ...

NASA sees Tropical Storm Julio now far from Hawaii

2014-08-14

Hurricane Julio moved past the Hawaiian Islands like a car on a highway in the distance, and NASA's Terra satellite captured an image of the storm, now downgraded to a tropical storm located more than 700 miles away. Julio is far enough away from Hawaii so that there are no coastal watches or warnings in effect. On August 13 at 21:10 UTC (5:10 p.m. EDT), the Moderate Resolution Imaging Spectroradiometer of MODIS instrument aboard NASA's Terra satellite captured a visible image of Hurricane Julio moving through the Central Pacific Ocean. The visible image shows that powerful ...

EARTH Magazine: Are slow-slip earthquakes under Tokyo stressing faults?

2014-08-14

Alexandria, Va. — Tokyo, a city of more than 13 million people, has been devastated by earthquakes in the past and likely will be again. But when? And what role do ongoing slow-slip earthquakes — the kind that generally can't be felt at the surface — play in relieving or building up stress? New research examining plate movements under Tokyo has found that since the massive magnitude-9 Tohoku earthquake and tsunami in March 2011, recurrence intervals for nondamaging slow-slip quakes beneath Japan's capital have shortened. That has left seismologists wondering if this aseismic ...

A husband's declining health could put Taiwanese women at risk for health issues

2014-08-14

PRINCETON, N.J.—The death of a spouse undoubtedly brings with it stress, anxiety and uncertainty. Now, a report by Princeton University's Woodrow Wilson School of Public and International Affairs quantifies this stress, showing how a husband's declining health could put Taiwanese women at risk for health issues. Using data from a longitudinal sample of Taiwanese older adults, the researchers found that the more a husband suffered, the more his wife's glucose levels increased. Yet, when a wife's health was declining, her husband's levels remained the same. Being widowed, ...

High prevalence of opioid use by Social Security disability recipients, reports Medical Care

2014-08-14

August 14, 2014 – More than 40 percent of Social Security Disability Insurance (SSDI) recipients take opioid pain relievers, while the prevalence of chronic opioid use is over 20 percent and rising, reports a study in the September issue of Medical Care. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health. The high proportion of SSDI recipients who are chronic opioid users—in many, at high and very high daily doses—"is worrisome in light of established and growing evidence that intense opioid use to treat non-malignant [non-cancer] ...

Tropical Storm Karina forms in Eastern Pacific near Socorro Island

2014-08-14

Socorro Island in the Eastern Pacific received an unwelcome tropical visitor on the morning of August 13 when satellite data confirmed the formation of Tropical Storm Karina. Karina strengthened from the eleventh tropical depression in the Eastern Pacific. Tropical Depression 11-E formed at 11 p.m. EDT on August 12. Just twelve hours later at 11 a.m. EDT, the depression had become better organized and winds increased to tropical storm strength. NOAA's GOES-West satellite captured an infrared image of newborn Tropical Storm Karina approaching Socorro Island in the Eastern ...

LAST 30 PRESS RELEASES:

Project to redesign clinical trials for neurologic conditions for underserved populations funded with $2.9M grant to UTHealth Houston

Menarini Group and Insilico Medicine enter a second exclusive global license agreement for an AI discovered preclinical asset targeting high unmet needs in oncology